RAD
RADIOPHARM FPO [RAD]
Healthcare · ASX Small Cap
$0.0220 -4.4%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical40
Catalyst50
Sentiment50
Fundamental70
Momentum57
Risk Gate30
Active Signals
Bullish Signals
- Volatility contracting (breakout setup)
- Low cash runway (3 quarters) - dilution risk
- 4C filed 2026-01-27
- Low P/S ratio (4.3x)
- EPS estimates revised upward (+10pts)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (10%)
- Altman Z-Score in distress zone (0.45 < 1.81)
- Low-priced stock risk ($0.023)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Year Report and Appendix 4D 31 December 2025
NONE RAD Doses First Patient in 177Lu-BetaBart (RV-01) Study
NONE RAD Increases Ownership in Radiopharm Ventures to 87.5%
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-27 | Half Year Report and Appendix 4D 31 December 2025 PRICE SENSITIVE |
| 2026-02-23 | RAD Doses First Patient in 177Lu-BetaBart (RV-01) Study PRICE SENSITIVE |
| 2026-01-27 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-11 | RAD Increases Ownership in Radiopharm Ventures to 87.5% |
| 2026-01-06 | Change in substantial holding |
Key Metrics
$54.4M
Market Cap
3.4M
Avg Volume
1.0x
Vol Ratio
$0.02 — $0.04
52-Week Range
0.1%
Short Interest
3 qtrs
Cash Runway
-109.2%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 67% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | pass | Inst: 10% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #41 of 119 · Sector avg: 51
View all Healthcare signals →